Abstract
Hydrazones are a versatile linker of connecting various classes of organic compounds with a unique structural feature of hydrogen bonding donor and the hydrogen bonding acceptor region. An extensive number of research has been carried out on hydrazone derivatives as a potent class of antitubercular agents. The present review focuses on the chemistry, antitubercular activity and structure activity relationship (SAR) of diverse classes of phenyl and heterocyclic based hydrazones.
Keywords: Alamar blue assay, nucleophilic addition, tuberculosis.
Infectious Disorders - Drug Targets
Title:Hydrazones as a Privileged Structural Linker in Antitubercular Agents: A Review
Volume: 15 Issue: 2
Author(s): Bijo Mathew, Jerad Suresh, Mohamed J. Ahsan, Githa E. Mathew, Dhasthakeer Usman, Puthucode N.S. Subramanyan, Kallivalappil F. Safna and Srinubabu Maddela
Affiliation:
Keywords: Alamar blue assay, nucleophilic addition, tuberculosis.
Abstract: Hydrazones are a versatile linker of connecting various classes of organic compounds with a unique structural feature of hydrogen bonding donor and the hydrogen bonding acceptor region. An extensive number of research has been carried out on hydrazone derivatives as a potent class of antitubercular agents. The present review focuses on the chemistry, antitubercular activity and structure activity relationship (SAR) of diverse classes of phenyl and heterocyclic based hydrazones.
Export Options
About this article
Cite this article as:
Mathew Bijo, Suresh Jerad, Ahsan J. Mohamed, Mathew E. Githa, Usman Dhasthakeer, Subramanyan N.S. Puthucode, Safna F. Kallivalappil and Maddela Srinubabu, Hydrazones as a Privileged Structural Linker in Antitubercular Agents: A Review, Infectious Disorders - Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1871526515666150724104411
DOI https://dx.doi.org/10.2174/1871526515666150724104411 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Remarkably Faster Approach Towards 1,2,3-Triazolyl Quinolines Via CuAAC in Water: Their Crystal Structure Analysis and Antibacterial Activities
Letters in Drug Design & Discovery Thiocoumarins and Dithiocoumarins: Advances in Synthesis and Pharmacological Activity
Current Organic Chemistry Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines
Current Pharmaceutical Biotechnology Decaprenylphosphoryl-β-D-Ribose 2-Epimerase from Mycobacterium tuberculosis is a Magic Drug Target
Current Medicinal Chemistry Hydrogel-clay Nanocomposites as Carriers for Controlled Release
Current Medicinal Chemistry Nanoparticles for Gene Delivery: A Brief Patent Review
Recent Patents on Drug Delivery & Formulation Recent Patents on Self-Quenching DNA Probes
Recent Patents on DNA & Gene Sequences A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches
Current Drug Targets Advances in Mycobacterial Isocitrate Lyase Targeting and Inhibitors
Current Medicinal Chemistry Graphical Abstracts
Medicinal Chemistry Patent Selections
Recent Patents on Biotechnology Bacterial Fatty Acid Synthesis: Effect of Tween 80 on Antibiotic Potency Against Streptococcus Agalactiae and Methicillin-Resistant Staphylococcus Aureus
Anti-Infective Agents Antimicrobial Peptides with pH-Dependent Activity and Alkaline Optima: Their Origins, Mechanisms of Action and Potential Applications
Current Protein & Peptide Science Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design Editorial from Guest Editor (Thematic Issue: Tuberculosis: Recent Advances in Our Understanding and Management)
Current Respiratory Medicine Reviews Chemical and Medicinal Versatility of Substituted 1,4-Dihydropyridines
Current Bioactive Compounds New insights on Ethambutol Targets in Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Isoniazid Induced Metabolic Acidosis and Renal Dysfunction in an Elderly Patient with Chronic Renal Disease
Current Drug Safety Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
Current Medicinal Chemistry Emerging Roles for the CD36 Scavenger Receptor as a Potential Therapeutic Target for Corneal Neovascularization
Endocrine, Metabolic & Immune Disorders - Drug Targets